Citadel Advisors
AXNX

Citadel Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Citadel Advisors’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-58,300
Closed -$4.06M – 15693
2024
Q3 		$4.06M Buy
58,300
+32,000
+122% +$2.19M ﹤0.01% 4288
2024
Q2 		$1.77M Buy
26,300
+18,600
+242% +$1.25M ﹤0.01% 5547
2024
Q1 		$531K Sell
7,700
-9,600
-55% -$648K ﹤0.01% 8262
2023
Q4 		$1.08M Buy
17,300
+2,700
+18% +$151K ﹤0.01% 6523
2023
Q3 		$819K Buy
14,600
+3,800
+35% +$214K ﹤0.01% 6993
2023
Q2 		$545K Buy
10,800
+8,800
+440% +$468K ﹤0.01% 7757
2023
Q1 		$109K Buy
2,000
+700
+54% +$40.9K ﹤0.01% 11125
2022
Q4 		$81.3K Buy
+1,300
New +$86.3K ﹤0.01% 11509
2022
Q2 		– Sell
-13,700
Closed -$858K – 14365
2022
Q1 		$858K Sell
13,700
-11,600
-46% -$625K ﹤0.01% 8060
2021
Q4 		$1.42M Sell
25,300
-20,700
-45% -$1.26M ﹤0.01% 7025
2021
Q3 		$2.99M Buy
46,000
+200
+0.4% +$13.7K ﹤0.01% 5371
2021
Q2 		$2.9M Buy
45,800
+28,700
+168% +$1.69M ﹤0.01% 5680
2021
Q1 		$1.02M Sell
17,100
-11,400
-40% -$620K ﹤0.01% 8049
2020
Q4 		$1.42M Buy
28,500
+23,900
+520% +$1.12M ﹤0.01% 6060
2020
Q3 		$235K Buy
+4,600
New +$192K ﹤0.01% 8563

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Citadel Advisors's AXNX Position: Q4 2024 in Review

Citadel Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 170,323 shares — an estimated $11.9M sold.

Citadel Advisors first reported a position in AXNX in Q4 2018 and held it in 24 quarters. The position peaked at $46M in Q1 2021. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Citadel Advisors reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Citadel Advisors sold 170,323 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $11.9M.
  • Citadel Advisors first reported a position in Axonics, Inc. Common Stock in Q4 2018 and held it in 24 quarters.
  • Citadel Advisors's Axonics, Inc. Common Stock position peaked at $46M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.